ND0701, A Novel Formulation of Apomorphine for Subcutaneous Infusion, in Comparison to a Commercial Apomorphine Formulation: 28-Day Pharmacokinetic Study in Minipigs and a Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Relative Bioavailability

被引：0
|
作者：
Yuval Ramot
Abraham Nyska
Liat Adar
Cecile Durlach
Danny Fishelovitch
Giuseppe Sacco
Rosa Anna Manno
Sheila Oren
Itay Perlstein
Oron Yacobi-Zeevi
机构：
[1] Hadassah-Hebrew University Medical Center,
[2] Tel Aviv University,undefined
[3] NeuroDerm Ltd.,undefined
[4] Research Toxicology Centre,undefined
[5] Magic Wand Research,undefined
[6] LLC,undefined
来源：
CNS Drugs | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：443 / 454
页数：11
相关论文
共 8 条
  • [1] ND0701, A Novel Formulation of Apomorphine for Subcutaneous Infusion, in Comparison to a Commercial Apomorphine Formulation: 28-Day Pharmacokinetic Study in Minipigs and a Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Relative Bioavailability
    Ramot, Yuval
    Nyska, Abraham
    Adar, Liat
    Durlach, Cecile
    Fishelovitch, Danny
    Sacco, Giuseppe
    Manno, Rosa Anna
    Oren, Sheila
    Perlstein, Itay
    Yacobi-Zeevi, Oron
    CNS DRUGS, 2018, 32 (05) : 443 - 454
  • [2] Ninety-day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs
    Ramot, Yuval
    Nyska, Abraham
    Maronpot, Robert R.
    Shaltiel-Karyo, Ronit
    Tsarfati, Yonit
    Manno, Rosa Anna
    Sacco, Giuseppe
    Yacoby-Zeevi, Oron
    TOXICOLOGIC PATHOLOGY, 2017, 45 (06) : 764 - 773
  • [3] A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects
    Ma, Junlong
    Huang, Jie
    Zou, Chan
    Wu, Qian
    Xie, Jinlian
    Zhang, Xingfei
    Yang, Xiaoyan
    Yang, Shuang
    Wu, Ziteng
    Jiang, Yan
    Yu, Sen
    Zhang, Xuqing
    Yang, Guoping
    Li, Mingyuan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 2303 - 2313
  • [4] Safety and Tolerability of Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor, During a 28-Day, Randomized, Placebo-Controlled, Phase I Clinical Study in Healthy Male Volunteers
    Davis, John
    Hackman, Frances
    Ndongo, Marie-Noella
    Choo, HengWee
    Lewis, Drew
    Tawadrous, Margaret
    Goodrich, James
    Langdon, Grant
    CLINICAL THERAPEUTICS, 2010, 32 (11) : 1889 - 1895
  • [5] A Phase 1 Study to Assess Safety, Tolerability, and Pharmacokinetics of PUR3100, a Novel Dry Powder Formulation of Dihydroergotamine for Oral Inhalation, in Healthy Adults.
    Wasilewski, M.
    Bodie, S.
    Gonzalez, Nelson A.
    Clayton, R.
    Curran, A.
    HEADACHE, 2023, 63 : 114 - 115
  • [6] A Phase 1 Study to Assess the Relative Bioavailability, Food Effect, and Safety of a Tablet Formulation of GSK2838232, a Novel HIV Maturation Inhibitor in Healthy Participants After Single and Repeated Doses
    Johnson, Mark
    Jewell, Roxanne C.
    Gan, Jianjun
    Dumont, Etienne
    Burns, Olivia
    Johns, Brian A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (08): : 972 - 977
  • [7] Results of a phase I, single dose, randomized, 3-way crossover study, to assess the bioavailability of a novel anagrelide extended release (ER) formulation in com-parison to a commerically available anagrelide reference product (CARP) in healthy volunteers
    Petrides, P.
    Zagrijtschuk, O.
    Klade, C.
    Oncology Research and Treatment, 2015, 38 : 228 - 228
  • [8] A Phase 1b/2a Open-Label, Multiple-Ascending Dose Cohort Study to Assess the Safety, Tolerability, Pilot Efficacy, Pharmacokinetics and Pharmacodynamic Effects of 28-Day Repeat Subcutaneous Doses of AKB-9778 in Subjects with Diabetic Macular Edema
    Brigell, Mitchell G.
    Campochiaro, Peter A.
    Sophie, Raafay
    Tolentino, Michael
    Miller, Daniel
    Browning, David
    Boyer, David S.
    Heier, Jeffrey S.
    Peters, Kevin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
1